This is a demo store. No orders will be fulfilled.

Recombinant Human CD30/TNFRSF8 Protein

  • 表达系统: HEK293
  • Accession #: P28908
  • 蛋白标签: C-His
  • 生物活性: Immobilized Recombinant Human CD30 Protein (rp169577) at 1.0 μg/mL can bind Brentuximab (anti-TNFRSF8) (Ab170548) with the EC50 of 119.9 ng/mL.
  • 内毒素水平: <1.0 EU/μg
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
rp169577-10μg
10μg 现货 Stock Image
rp169577-50μg
50μg 现货 Stock Image
rp169577-100μg
100μg 现货 Stock Image
rp169577-1mg
1mg 现货 Stock Image

基本描述

产品名称 Recombinant Human CD30/TNFRSF8 Protein
别名 重组人CD30/TNFRSF8蛋白 | 重组人 CD30/TNFRSF8 蛋白
英文别名 CD30 | CD30KI-1 | CD30L receptor | cytokine receptor CD30 | D1S166EKi-1 | Ki-1 antigen | Lymphocyte activation antigen CD30 | TNFRSF8 | tumor necrosis factor receptor superfamily member 8 | tumor necrosis factor receptor superfamily, member 8 | CD30 antig
规格或纯度 Animal Free, Carrier Free, Bioactive, ActiBioPure™, ≥95%(SDS-PAGE)
产品介绍


Protein Function::
CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor (TNFR) superfamily. CD30 protein is expressed by activated, but not resting, T and B cells. CD30 can regulate proliferation of lymphocytes and may also play an important role in human immunodeficiency virus replication. As a regulator of apoptosis, CD30 protein induces cell death or proliferation, depending on the cell type, and has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. CD30 protein expression is upregulated in various hematological malignancies, including Reed-Sternberg cells in Hodgkin's disease (HD), anaplastic large cell lymphoma (ALCL) and subsets of Non-Hodgkin's lymphomas (NHLs), and CD30 is also linked to leukocytes in patients with chronic inflammatory diseases, including lupus erythematosus, asthma, rheumatoid arthritis and atopic dermatitis (AD). 

生物活性 Immobilized Recombinant Human CD30 Protein (rp169577) at 1.0 μg/mL can bind Brentuximab (anti-TNFRSF8) (Ab170548) with the EC50 of 119.9 ng/mL.
内毒素水平 <1.0 EU/μg
表达系统 HEK293
种属 人(Human)
氨基酸 1-379 aa
序列 MRVLLAALGLLFLGALRAFPQDRPFEDTCHGNPSHYYDKAVRRCCYRCPMGLFPTQQCPQRPTDCRKQCEPDYYLDEADRCTACVTCSRDDLVEKTPCAWNSSRVCECRPGMFCSTSAVNSCARCFFHSVCPAGMIVKFPGTAQKNTVCEPASPGVSPACASPENCKEPSSGTIPQAKPTPVSPATSSASTMPVRGGTRLAQEAASKLTRAPDSPSSVGRPSSDPGLSPTQPCPEGSGDCRKQCEPDYYLDEAGRCTACVSCSRDDLVEKTPCAWNSSRTCECRPGMICATSATNSCARCVPYPICAAETVTKPQDMAEKDTTFEAPPLGTQPDCNPTPENGEAPASTSPTQSLLVDSQASKTLPIPTSAPVALSSTGK​HHHHHH
蛋白标签 C-His
无载体 Yes
无动物源 Yes
Accession # P28908
来源 重组表达
预测分子量 39.2 kDa
SDS-PAGE 55.0-99.0 kDa, under reducing conditions

储存与运输

物理形态 冻干(Lyophilized)
储存缓冲液 Lyophilized from PBS, pH7.4
复溶 We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute at 1.0 mg/mL in sterile distilled water. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.
储存温度 -20°C储存,避免反复冻融
运输条件 超低温冰袋运输
稳定性与储存 在 -20°C 下可保存 1 年。避免冷冻/解冻循环。
分子类型 蛋白质

图片

Recombinant Human CD30/TNFRSF8 Protein (rp169577) - ELISA
Immobilized Recombinant Human CD30/TNFRSF8 Protein (rp169577) at 1.0 μg/mL can bind Brentuximab (anti-TNFRSF8) (Ab170548) with the EC₅₀ of 119.9 ng/mL.


Recombinant Human CD30/TNFRSF8 Protein (rp169577) - SDS-PAGE
3 μg/lane of Recombinant Human CD30/TNFRSF8 Protein was resolved with SDS-PAGE under reducing (R) and visualized by Coomassie® Blue staining, showing a band at 55.0-99.0 kDa under reducing conditions.

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到4个结果

批号(Lot Number) 证书类型 货号
ZJ24F0708053 分析证书 rp169577
ZJ24F0708050 分析证书 rp169577
ZJ24F0708051 分析证书 rp169577
ZJ24F0708052 分析证书 rp169577

溶液计算器